Induced pluripotent stem cells for the treatment of liver diseases: challenges and perspectives from a clinical viewpoint

The only curative treatment for severe end-stage liver disease (ESLD) is liver transplantation (LT) but it is limited by the shortage of organ donors. The increase of the incidence of liver disease has led to develop new therapeutic approaches such as liver cell transplantation. Current challenges t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pareja, Eugenia, Gómez-Lechón, M. José, Tolosa, Laia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article on Stem Cell and Clinical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347783/
https://www.ncbi.nlm.nih.gov/pubmed/32775367
http://dx.doi.org/10.21037/atm.2020.02.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347783/
https://www.ncbi.nlm.nih.gov/pubmed/32775367
http://dx.doi.org/10.21037/atm.2020.02.164

Ejemplares similares